Related Experiment Videos
Evaluating Routine Opioid Compared With Nonopioid Prescribing After Laparoscopic Hysterectomy: A Randomized
Marie-Claire Leaf1, Julia Wainger, Anja Frost
1Department of Gynecology and Obstetrics, the Division of General Internal Medicine, Department of Medicine, and the Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland; and the Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut.
Obstetrics and Gynecology
|July 31, 2026
Summary
A nonopioid pain regimen after minimally invasive hysterectomy is as effective as routine opioids. This approach significantly reduces opioid consumption, supporting opioid-sparing strategies in gynecologic surgery.
Area of Science:
- Gynecologic Surgery
- Pain Management
- Pharmacology
Background:
- Minimally invasive hysterectomy is a common gynecologic procedure.
- Postoperative pain management often involves opioids, raising concerns about dependence and side effects.
- Developing effective nonopioid pain strategies is crucial for patient recovery and public health.
Purpose of the Study:
- To compare the noninferiority of a nonopioid pain regimen versus a routine opioid regimen after minimally invasive hysterectomy.
- To assess patient satisfaction with pain control in both treatment arms.
- To evaluate opioid consumption in patients receiving nonopioid versus opioid-based pain management.
Main Methods:
- A noninferiority randomized controlled trial was conducted with adult patients undergoing hysterectomy for benign conditions.
- Patients were randomized to either a nonopioid (acetaminophen, ibuprofen) or a standard opioid (acetaminophen, ibuprofen, oxycodone) regimen.
- Pain scores (NRS-11) and patient satisfaction were primary outcomes, with opioid consumption as a secondary outcome.
Main Results:
- Mean pain scores on postoperative days 1 and 7 were similar between the nonopioid and opioid groups, meeting noninferiority criteria.
- Patient satisfaction with pain control was high across both groups.
- Median oxycodone consumption by postoperative day 7 was significantly lower in the nonopioid group (0 tablets) compared to the opioid group (1 tablet).
Conclusions:
- Nonopioid pain management is noninferior to routine opioid prescribing for minimally invasive hysterectomy.
- This strategy substantially reduces opioid use, supporting opioid-sparing approaches.
- Nonopioid regimens offer a safe and effective alternative for postoperative pain control in this patient population.